Skip to main content

Publications

394 publications

Active

8 grants
  • PI
    Understanding and Targeting Aberrant RNA Splicing in Leukemia
    NCI · 2025–2032 · via NIH RePORTER
  • MPI
    Project 3: Understanding the impact of targeting of nuclear m6A RNA methylation reader YTHDC1 in AML
    NCI · 2021–2031 · via NIH RePORTER
  • PI
    MSK Paul Calabresi Career Development Award for Clinical Oncology
    NCI · 2015–2030 · via NIH RePORTER
  • MPI
    Investigational Cancer Therapeutics Training Program (ICTTP)
    NCI · 1977–2029 · via NIH RePORTER
  • PI
    Genetic and molecular basis for SRSF2 mutations in myelodysplasia
    NHLBI · 2015–2029 · via NIH RePORTER
  • PI
    Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
    NCI · 2023–2028 · via NIH RePORTER
  • KP
    Characterizing neoantigen-specific T cell immunity and T-cell receptor repertoire in spliceosomal mutant myeloid leukemias
    American Society of Hematology Inc · 2024–2026
    ASHI 240541-01
  • MPI
    Charting the differentiation topology of SF3B1 mutated clonal hematopoiesis (CH) and myelodysplastic syndromes (MDS) via a multi-omics single-cell toolkit
    NHLBI · 2022–2026 · via NIH RePORTER
Completed grants (5)
  • PI
    Interrogating the minor spliceosome to understand and treat leukemia
    NCI · 2020–2025 · via NIH RePORTER
  • PI
    Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia
    NCI · 2020–2025 · via NIH RePORTER
  • MPI
    ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
    NCI · 2019–2025 · via NIH RePORTER
  • PI
    Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance
    NCI · 2016–2021 · via NIH RePORTER
  • PI
    Role of ASXL1 mutations in myeloid malignancies
    NCI · 2011–2016 · via NIH RePORTER

News mentions